Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

RPS6KA3 anticorps

RPS6KA3 Reactivité: Humain WB, ELISA, FACS, ICC Hôte: Souris Monoclonal 4E10 unconjugated
N° du produit ABIN969386
  • Antigène Voir toutes RPS6KA3 Anticorps
    RPS6KA3 (Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3))
    Reactivité
    • 172
    • 114
    • 65
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 174
    • 16
    • 1
    Souris
    Clonalité
    • 174
    • 17
    Monoclonal
    Conjugué
    • 72
    • 11
    • 9
    • 8
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 2
    Cet anticorp RPS6KA3 est non-conjugé
    Application
    • 96
    • 68
    • 67
    • 52
    • 30
    • 25
    • 17
    • 16
    • 14
    • 6
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Fonction
    RSK2 Antibody
    Purification
    Ascitic fluid
    Immunogène
    Purified recombinant fragment of human RSK2 expressed in E. Coli.
    Clone
    4E10
    Isotype
    IgG1
  • Indications d'application

    ELISA: 1/10000

    FCM: 1/200 - 1/400

    ICC: 1/200 - 1/1000

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Dehan, Bassermann, Guardavaccaro, Vasiliver-Shamis, Cohen, Lowes, Dustin, Huang, Taunton, Pagano: "betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis." dans: Molecular cell, Vol. 33, Issue 1, pp. 109-16, (2009) (PubMed).

    Cho, Yao, Pugliese, Malakhova, Bode, Dong: "A regulatory mechanism for RSK2 NH(2)-terminal kinase activity." dans: Cancer research, Vol. 69, Issue 10, pp. 4398-406, (2009) (PubMed).

  • Antigène
    RPS6KA3 (Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3))
    Autre désignation
    RSK2 (RPS6KA3 Produits)
    Sujet

    Description: This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS).

    Aliases: RPS6KA3, CLS, RSK, HU-3, RSK2, MRX19, ISPK-1, p90-RSK2, pp90RSK2, MAPKAPK1B, S6K-alpha3

    Poids moléculaire
    80kDa
    ID gène
    6197
    HGNC
    6197
    UniProt
    P51812
    Pathways
    Signalisation MAPK, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades
Support technique
Close menu